HBK Sorce Advisory’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267K Buy
6,174
+1,486
+32% +$69.3K 0.01% 517
2025
Q4
$224K Sell
4,688
-314
-6% -$15.6K 0.01% 555
2025
Q3
$245K Buy
5,002
+83
+2% +$4.01K 0.01% 522
2025
Q2
$238K Buy
4,919
+120
+3% +$6.13K 0.01% 510
2025
Q1
$266K Buy
4,799
+532
+12% +$28.8K 0.01% 481
2024
Q4
$206K Buy
4,267
+391
+10% +$19.9K 0.01% 535
2024
Q3
$223K Sell
3,876
-420
-10% -$22.7K 0.01% 516
2024
Q2
$208K Buy
+4,296
New +$207K 0.01% 516
2017
Q4
Sell
-4,071
Closed -$203K 394
2017
Q3
$203K Buy
+4,071
New +$197K 0.03% 301

Other funds holding SNY

HBK Sorce Advisory's SNY Position: Q1 2026 in Review

HBK Sorce Advisory increased its Sanofi (SNY) stake by 32% in Q1 2026, buying an estimated $69.3K and bringing the position to 6,174 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #517.

HBK Sorce Advisory first reported a position in SNY in Q3 2017 and has held it in 9 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • HBK Sorce Advisory held 6,174 shares of Sanofi worth $267K as of Q1 2026.
  • HBK Sorce Advisory bought 1,486 Sanofi shares in Q1 2026, an estimated $69.3K.
  • Sanofi made up 0.01% of HBK Sorce Advisory's portfolio in Q1 2026, its #517 holding.
  • HBK Sorce Advisory first reported a position in Sanofi in Q3 2017 and has held it in 9 quarters since.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.